NL177749C - N-(fenoxyalkyl)imidazolen en farmaceutische preparaten die deze verbindingen als werkzame stof bevatten. - Google Patents

N-(fenoxyalkyl)imidazolen en farmaceutische preparaten die deze verbindingen als werkzame stof bevatten.

Info

Publication number
NL177749C
NL177749C NLAANVRAGE7908899,A NL7908899A NL177749C NL 177749 C NL177749 C NL 177749C NL 7908899 A NL7908899 A NL 7908899A NL 177749 C NL177749 C NL 177749C
Authority
NL
Netherlands
Prior art keywords
phenoxyalkyl
imidazoles
compounds
active substance
pharmaceutical preparations
Prior art date
Application number
NLAANVRAGE7908899,A
Other languages
English (en)
Dutch (nl)
Other versions
NL7908899A (nl
NL177749B (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL177749(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of NL7908899A publication Critical patent/NL7908899A/nl
Publication of NL177749B publication Critical patent/NL177749B/xx
Application granted granted Critical
Publication of NL177749C publication Critical patent/NL177749C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NLAANVRAGE7908899,A 1978-12-13 1979-12-11 N-(fenoxyalkyl)imidazolen en farmaceutische preparaten die deze verbindingen als werkzame stof bevatten. NL177749C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13
GB7848367 1978-12-13

Publications (3)

Publication Number Publication Date
NL7908899A NL7908899A (nl) 1980-06-17
NL177749B NL177749B (nl) 1985-06-17
NL177749C true NL177749C (nl) 1985-11-18

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7908899,A NL177749C (nl) 1978-12-13 1979-12-11 N-(fenoxyalkyl)imidazolen en farmaceutische preparaten die deze verbindingen als werkzame stof bevatten.

Country Status (34)

Country Link
US (2) US4602016A (ru)
JP (1) JPS585197B2 (ru)
KR (1) KR830001243B1 (ru)
AR (1) AR227637A1 (ru)
AT (1) AT373879B (ru)
AU (1) AU517892B2 (ru)
BE (1) BE880584A (ru)
CA (1) CA1108137A (ru)
CH (1) CH644597A5 (ru)
CS (1) CS216517B2 (ru)
DD (1) DD147943A5 (ru)
DE (1) DE2950019A1 (ru)
DK (1) DK471479A (ru)
EG (1) EG14227A (ru)
ES (1) ES8101556A1 (ru)
FI (1) FI70888C (ru)
FR (1) FR2444031A1 (ru)
GB (1) GB2038821B (ru)
GR (1) GR73003B (ru)
HU (1) HU183016B (ru)
IE (1) IE49318B1 (ru)
IL (1) IL58917A (ru)
IT (1) IT1194900B (ru)
LU (1) LU81985A1 (ru)
NL (1) NL177749C (ru)
NO (1) NO153135C (ru)
NZ (1) NZ192360A (ru)
PH (1) PH15056A (ru)
PL (1) PL134005B1 (ru)
PT (1) PT70571A (ru)
SE (1) SE444937B (ru)
SU (1) SU878195A3 (ru)
YU (1) YU301879A (ru)
ZA (1) ZA796708B (ru)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES539074A0 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
US4894385A (en) * 1985-01-16 1990-01-16 Sankyo Company Limited Imidazole derivatives as inhibitors of TXA2 synthesis
NO166644C (no) 1986-01-28 1991-08-21 Sankyo Co Analogifremgangsmaate til fremstilling av tianaftenderivater.
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
EP0284892B1 (de) * 1987-04-03 1990-10-31 Cl Pharma Aktiengesellschaft Neue 2-Thienyloxyessigsäurederivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
AU2890899A (en) * 1998-03-13 1999-09-27 Pozen, Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
JP2005533830A (ja) * 2002-07-09 2005-11-10 ビー．エム．アール．エイ． コーポレイション ベスローテン フェンノートシャップ トロンボキサンａ２受容体アンタゴニストおよびｃｏｘ−２阻害剤の薬剤の組み合わせ
CA2534316A1 (en) * 2003-08-07 2005-02-24 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxygenase-1
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
EP2543368A1 (en) 2007-12-11 2013-01-09 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
EA026393B1 (ru) * 2012-05-22 2017-04-28 Дженентек, Инк. N-замещенные бензамиды и их применение в лечении боли
RU2015119640A (ru) 2012-10-26 2016-12-20 Мерк Шарп И Доум Корп. Соединения n-замещенного индазол-сульфонамида с избирательной активностью в потенциал-зависимых натриевых каналах
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途
WO2023240378A1 (zh) * 2022-06-13 2023-12-21 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
JPS585197B2 (ja) 1983-01-29
AU517892B2 (en) 1981-09-03
SE7910204L (sv) 1980-06-14
ATA783379A (de) 1983-07-15
CS216517B2 (en) 1982-11-26
CH644597A5 (de) 1984-08-15
AU5372579A (en) 1980-06-19
IL58917A0 (en) 1980-03-31
NZ192360A (en) 1982-02-23
KR830001243B1 (ko) 1983-06-27
PL134005B1 (en) 1985-07-31
CA1108137A (en) 1981-09-01
ES486782A0 (es) 1980-12-16
DK471479A (da) 1980-06-14
DE2950019A1 (de) 1980-07-10
IT1194900B (it) 1988-09-28
LU81985A1 (fr) 1980-04-22
AT373879B (de) 1984-02-27
AR227637A1 (es) 1982-11-30
HU183016B (en) 1984-04-28
NO153135C (no) 1986-01-22
YU301879A (en) 1983-01-21
DD147943A5 (de) 1981-04-29
FR2444031A1 (fr) 1980-07-11
IT7941669A0 (it) 1979-12-11
SE444937B (sv) 1986-05-20
GB2038821A (en) 1980-07-30
IE792403L (en) 1980-06-13
FI793868A (fi) 1980-06-14
EG14227A (en) 1983-12-31
JPS5585572A (en) 1980-06-27
FI70888C (fi) 1986-10-27
NL7908899A (nl) 1980-06-17
NL177749B (nl) 1985-06-17
KR830001242A (ko) 1983-04-29
GR73003B (ru) 1984-01-24
NO153135B (no) 1985-10-14
PL220351A1 (ru) 1980-12-01
ZA796708B (en) 1981-08-26
US4636500A (en) 1987-01-13
US4602016A (en) 1986-07-22
BE880584A (fr) 1980-06-12
IE49318B1 (en) 1985-09-18
PT70571A (en) 1980-01-01
FR2444031B1 (ru) 1983-06-10
GB2038821B (en) 1982-12-08
PH15056A (en) 1982-06-03
IL58917A (en) 1984-03-30
SU878195A3 (ru) 1981-10-30
NO794069L (no) 1980-06-16
ES8101556A1 (es) 1980-12-16
FI70888B (fi) 1986-07-18

Similar Documents

Publication Publication Date Title
NL177749C (nl) N-(fenoxyalkyl)imidazolen en farmaceutische preparaten die deze verbindingen als werkzame stof bevatten.
NL7907583A (nl) Heterocyclische verbindingen, in het bijzonder indool- verbindingen, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL8103768A (nl) Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7708741A (nl) Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten.
NL7803195A (nl) Heterocyclische verbindingen met farmaceutische activiteit, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten, die deze verbindingen als actieve component bevatten.
NL192265B (nl) Penemcarbonzuur-verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7706064A (nl) Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
DK161184C (da) Baerer til veterinaerpraeparat
NL188645C (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
BE863835A (nl) Nieuwe 1-(diarylmethyl)-aminoalkyl)-piperidinen met neuroleptische werkzaamheid, alsmede therapeutische preparaten, die deze nieuwe piperidinen als werkzame stof bevatten
NL180664C (nl) 1,8-alkyleen-3-carboxy-4-oxo-7-piperazinochinolinederivaten, werkwijze voor de bereiding daarvan en anti-microbiele preparaten die een dergelijke verbinding als werkzame stof bevatten.
BE868022A (fr) Substance proteinique active
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NL7711414A (nl) Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7702180A (nl) Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7707150A (nl) Werkwijze ter bereiding van 2-lagere alkyl-7-ge- substitueerde-2 of 3-cefem-4-carbonzuurverbin- dingen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL8002959A (nl) Hydroxyamino-eburnaanderivaten en een werkwijze voor de bereiding hiervan en de toepassing als farmaceutisch actieve stof.
NL7909200A (nl) N-gesubstitueerde trifluorethylaminen, farmaceutische preparaten met als werkzaam bestanddeel een dergelijk n-gesubstitueerd trifluorethylamine erin, alsmede werkwijzen voor de bereiding van de werkzame bestand- delen.
NL7901251A (nl) Werkwijze voor het bereiden van een optisch actief ben- zamide, het op deze wijze verkregen optisch actieve benzamide en farmaceutische preparaten die deze ver- binding bevatten.
NL7904311A (nl) Hydantoinederivaten alsmede deze derivaten als actieve component bevattende farmaceutische preparaten.
NL188579B (nl) 3-(tetrazol-5-yl)-1-azaxanthonen, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7714063A (nl) Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten.
DK1280A (da) Substituerede benzoylimider og fremgangsmaade til fremstilling deraf samt insekticide praeparater indeholdende forbindelserne
NL7602993A (nl) Fysiologisch werkzame gesubstitueerde tetrazolen, alsmede werkwijze voor de bereiding daarvan en voor preparaten met deze verbindingen als aktie- ve stof.
NL7810758A (nl) Gesubstitueerde 7 beta-amidino-delta3-cefem-4-carbon- zuren alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee